686 Preclinical characterization of a novel therapeutic antibody targeting LILRB2

686 Preclinical characterization of a novel therapeutic antibody targeting LILRB2

Bibliographic Details
Main Authors:	Tao Huang, An Song, Ryan Stafford, Maria Jose Costa, Zhiqiang Ku, Jing-Tyan Ma, Krista McCutcheon, Xiaoye Liu, Heyu Chen, Kyu Hong, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang, X Charlene Liao
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

281 Fc gamma receptor crosslinking promotes antibody-induced LILRB4 internalization and immune regulation of acute monocytic leukemia
by: Joshua Morse, et al.
Published: (2023-04-01)

575 Preclinical characterization of LAE111, a potent anti-LILRB1/LILRB2 antagonist bispecific antibody
by: Rong Wu, et al.
Published: (2023-11-01)

LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
by: Peng Zhao, et al.
Published: (2022-06-01)

1356 DM926, a novel anti-LILRB1/LILRB2 dual antagonist antibody, promotes adaptive and innate immune response to enhance anti-tumor activity in preclinical models
by: Yi Xu, et al.
Published: (2023-11-01)

276 Discovery and preclinical characterization of anti-LILRB2 antibodies that rescue T cells from macrophage-mediated immune suppression
by: Lauren Loh, et al.
Published: (2021-11-01)

POS-686 UِSE OF BORTEZOMIB IN TREATMENT OF KIDNEY TRANSPLANT SUB-CLINICAL ANTIBODY MEDIATED REJECTION
by: A. AL-OMAIRI, et al.
Published: (2021-04-01)

519 OR641 is a novel dual antagonist antibody that targets LILRB1 and LILRB2 inhibitory receptors and promotes a Th1-like immune response
by: Peter Probst, et al.
Published: (2023-11-01)

Molecular regulatory mechanism of LILRB4 in the immune response
by: Haiyin Liu, et al.
Published: (2023-02-01)

Antibody therapies for the prevention and treatment of viral infections
by: Georgina Salazar, et al.
Published: (2017-07-01)

LILRB4 Decrease on uDCs Exacerbate Abnormal Pregnancy Outcomes Following Toxoplasma gondii Infection
by: Shaowei Zhan, et al.
Published: (2018-03-01)

LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
by: Myongchol Ryu, et al.
Published: (2011-04-01)

LILRB4, an immune checkpoint on myeloid cells
by: Ting Yang, et al.
Published: (2022-04-01)

Blocking LAIR1 signaling in immune cells inhibits tumor development
by: Jingjing Xie, et al.
Published: (2022-09-01)

LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets
by: Zhiqing Xiang, et al.
Published: (2024-02-01)

Antibody Therapies Targeting Complex Membrane Proteins
by: Georgina To'a Salazar, et al.
Published: (2021-11-01)

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis
by: Vipul K. Singh, et al.
Published: (2022-06-01)

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
by: Renheng Zou, et al.
Published: (2023-05-01)

Structural basis for RIFIN-mediated activation of LILRB1 in malaria
by: Harrison, TE, et al.
Published: (2020)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
by: Qiyuan Zhuang, et al.
Published: (2023-10-01)

AIRRscape: An interactive tool for exploring B-cell receptor repertoires and antibody responses.
by: Eric Waltari, et al.
Published: (2022-09-01)

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to <it>Salmonella </it>infection
by: Buerki Robin A, et al.
Published: (2009-10-01)

Kinetics of the High Temperature Oxidation of the Inconel 686 Coatings in the Waste Incineration Ash
by: M. Solecka, et al.
Published: (2021-12-01)

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
by: Ila Mishra, et al.
Published: (2021-04-01)

إدارة مصعب بن الزبیر للعراق 67 – 73هـ/ 686- 691م
by: صلاح الدین طه
Published: (2002-06-01)

Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings
by: Eva Germovsek, et al.
Published: (2021-01-01)

Change, continuity and cultural identity as traced through the people and place of Ambohimanga, Madagascar
by: McCutcheon, M, et al.
Published: (2003)

1391 Antibody targeting a specific epitope of LILRB4 induces potent ADCC/ADCP effect against leukemia cells
by: Peng Chen, et al.
Published: (2023-11-01)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
by: Tobias Zeller, et al.
Published: (2022-10-01)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
by: Dan-Pei Li, et al.
Published: (2023-07-01)

Functional Enrichment and Analysis of Antigen-Specific Memory B Cell Antibody Repertoires in PBMCs
by: Eric Waltari, et al.
Published: (2019-06-01)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
by: Giles, J, et al.
Published: (2010)

Space and astronomy : the people behind the science /
by: 294132 McCutcheon, Scott, et al.
Published: (2006)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
by: Tobias Zeller, et al.
Published: (2023-09-01)

510 ES008, a high affinity LILRB1 specific blocking antibody activates multiple immune cells to fight cancers
by: Rui Gao, et al.
Published: (2023-11-01)

494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses
by: Peter Probst, et al.
Published: (2023-11-01)

Placental Malaria is Associated with Higher LILRB2 Expression in Monocyte Subsets and Lower Anti-Malarial IgG Antibodies During Infancy
by: Celia Dechavanne, et al.
Published: (2022-07-01)

Backscattering in nonlinear microring resonators via a Gaussian treatment of coupled cavity modes
by: Will McCutcheon
Published: (2021-06-01)

<i>HLA-G</i>, <i>LILRB1</i> and <i>LILRB2</i> Variants in Zika Virus Transmission from Mother to Child in a Population from South and Southeast of Brazil
by: Amarilis Giaretta de Moraes, et al.
Published: (2022-06-01)

Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice
by: Yasuaki Anami, et al.
Published: (2018-06-01)

P686: Equity challenge: Examining how to improve genetic telehealth for patients in Detroit metro area
by: Hannah Kelley, et al.
Published: (2023-01-01)